Shanghai RunYoung Investment Management Company was established.
Hosted the 1st Sino-Israeli Medical Technology Industry Summit Forum in Beijing in cooperation with the Central Committee of the Chinese Peasants’ and Workers’ Democratic Party.
Signed an Exclusive Framework Cooperation Agreement with The Hebrew University Yissum technology transfer center.
Hosted the 2nd Sino-Israeli Medical Technology Industry Summit Forum in Changzhou in cooperation with the Central Committee of the Chinese Peasants’ and Workers’ Democratic Party.
Changzhou RunYoung Technology Transfer Center Company was established.
Signed an exclusive framework cooperation agreement with Mor Research Applications, the technology transfer office of the largest HMO in Israel; Clalit Health Services.
Invested in BrainQ, an Israeli company that has developed neuro-recovery technology for various neurological diseases.
Completed investment in Professor ELI Keshet’s (an academician of the Israeli Academy of Sciences) project to promote healthy aging through vascular regulation of VEGF.
Jointly established the West Taihu Lake China-Israel Biomedical Innovation Research Institute with Changzhou No. 4 Pharmaceutical Co.
Invested in the LIFT (Liquid Foam Therapy) drug delivery technology in Israel.
Invested in Israel’s VESSL technology platform; a combination of cell and gene therapy.
Invested in Israel’s AMD dry (atrophic) geriatric shift lesion project.
Signed nobel laureate Aaron Ciechanover as Honorary Chairman of RunYoung.
Built a medical device incubation platform in partnership with Hangzhou Kangji Medical Group.
Signed an exclusive partnership agreement with Sheba Medical Cente; a top ten hospital globally.
Signed a strategic cooperation agreement with CW Data to bring more Israeli technologies to China.
Completed investment in Nobel Prize Winner Aaron Ciechanover‘s project to diagnose and treat multiple myeloma.